Comments for discussion are due by Dec. 3, with a focus on the inclusion of certain bulk substances in compounding exemptions under Section 503A of the FD&C Act. The committee will review substances ...
The committee will discuss bulk drug substances being considered for inclusion on the 503A Bulk Drug Substances List, including AOD-9604-related, CJC-1295-related, and Thymosin alpha-1-related ...
The thymus is located in the chest, behind the sternum (breastbone). It is part of the lymphatic system and plays an important role in the immune system by creating lymphocytes called T cells. These ...